176 related articles for article (PubMed ID: 20339556)
1. Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.
Ang CW; Dijkstra JR; de Klerk MA; Endtz HP; van Doorn PA; Jacobs BC; Jeurissen SH; Wagenaar JA
PLoS One; 2010 Mar; 5(3):e9820. PubMed ID: 20339556
[TBL] [Abstract][Full Text] [Related]
2. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
5. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
7. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
9. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
Moran AP; Annuk H; Prendergast MM
J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Yuki N; Odaka M
Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
[TBL] [Abstract][Full Text] [Related]
12. Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni.
Linton D; Gilbert M; Hitchen PG; Dell A; Morris HR; Wakarchuk WW; Gregson NA; Wren BW
Mol Microbiol; 2000 Aug; 37(3):501-14. PubMed ID: 10931344
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
19. Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain.
Zhang M; Gilbert M; Yuki N; Cao F; Li J; Liu H; Li Q; Meng F; Zhang J
PLoS One; 2015; 10(7):e0131730. PubMed ID: 26197476
[TBL] [Abstract][Full Text] [Related]
20. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
